Dr. Donald Barry Boyd, MD

Dr. Boyd practices at Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System.

Dr. Boyd's NPI, 1396826376, was assigned on October 18, 2006. Dr. Boyd graduated from JS Weill Medical College, Cornell University in 1979. Dr. Boyd holds Connecticut license 27275.

Dr. Boyd's primary practice is Greenwich Hospital, at 5 Perryridge Rd, Greenwich, CT 06830 in Fairfield County. The practice phone is (203) 863-3000.

Dr. Boyd's primary practice is Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System. Dr. Boyd is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Boyd to 2 more hospitals, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boyd practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Boyd's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Boyd is licensed in Connecticut.

CMS data shows 1,057 Medicare services from Dr. Boyd across 8 procedure codes in 2024, for 349 Medicare patients. Medicare paid $104,627 for them.

CMS counts 349 Medicare patients who saw Dr. Boyd in 2024. The largest group is 75 to 84, with 146 patients. 72% of them have high cholesterol, and 66% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boyd's median patient age at 74, with 74% women.

In 2024, Dr. Boyd wrote 1,340 Medicare Part D claims for 195 patients. 84% of them were for generic drugs. CMS names the drug for 1,022 of them, across 41 drugs with 11 or more claims each, at $1,357,914 in total drug cost. In 2023, CMS named 953 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Boyd for performance year 2024, reported as part of a group. Dr. Boyd accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boyd as offering telehealth.

CMS Open Payments shows 253 general payments to Dr. Boyd from 17 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 80% of the total. Merck Sharp & Dohme Corporation paid the most, $221,511.

Dr. Boyd graduated from JS Weill Medical College, Cornell University in 1979.